Didem Ilter
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
-
- Tuberous Sclerosis Complex Research
Papers in
-
- Epigenetics and DNA Methylation 3
- Metabolism, Diabetes, and Cancer 2
- RNA modifications and cancer 2
- Histone Deacetylase Inhibitors Research 1
- Oncology 4
- Cytokine Signaling Pathways and Interactions 1
- Vascular Tumors and Angiosarcomas 1
- Cancer-related Molecular Pathways 1
- Co-authors
- John Blenis (4 shared papers)Ana P. Gomes (7 shared papers)Stanislav Drápela (5 shared papers)Elizabeth P. Henske (1 shared paper)Xiaoxiao Gu (1 shared paper)Jane Yu (1 shared paper)Wenjuan Zhang (1 shared paper)Sarah J. Mahoney (1 shared paper)
- Journals
- Cancer Research (1 paper)Molecular Oncology (1 paper)Journal of Biological Chemistry (1 paper)Oncogene (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesBelgiumSweden
In The Last Decade
Didem Ilter
9 papers receiving 210 citations
Peers
Comparison fields: 5 of 56
- Cancer Research 57
- Physiology 63
- Oncology 65
- Molecular Biology 117
- Rheumatology 22
Countries citing papers authored by Didem Ilter
This map shows the geographic impact of Didem Ilter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didem Ilter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didem Ilter more than expected).
Fields of papers citing papers by Didem Ilter
This network shows the impact of papers produced by Didem Ilter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didem Ilter. The network helps show where Didem Ilter may publish in the future.
Co-authors
The 25 scholars most cited alongside Didem Ilter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 55 | |
| 2 | 2022 | 54 | |
| 3 | 2012 | 50 | |
| 4 | 2022 | 21 | |
| 5 | 2023 | 21 | |
| 6 | 2024 | 4 | |
| 7 | 2020 | 3 | |
| 8 | 2021 | 2 | |
| 9 | 2024 | 1 |
About Didem Ilter
Didem Ilter is a scholar working on Molecular Biology, Oncology, Cancer Research, Epidemiology and Rheumatology, having authored 9 papers that have together received 211 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Epigenetics and DNA Methylation (3 papers), Metabolism, Diabetes, and Cancer (2 papers), RNA modifications and cancer (2 papers), Cytokine Signaling Pathways and Interactions (1 paper), Vascular Tumors and Angiosarcomas (1 paper), Cancer-related Molecular Pathways (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Cancer Research (57 citations), Physiology (63 citations), Oncology (65 citations), Molecular Biology (117 citations) and Rheumatology (22 citations). Didem Ilter has collaborated with scholars based in United States, Belgium and Sweden. Frequent co-authors include John Blenis, Ana P. Gomes, Stanislav Drápela, Elizabeth P. Henske, Xiaoxiao Gu, Jane Yu, Wenjuan Zhang, Sarah J. Mahoney, Yingmei Zhang and Dalong Ma. Their work appears in journals such as Cancer Research, Molecular Oncology, Journal of Biological Chemistry, Oncogene and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.